James S Frank insider trades: CPEX Pharmaceuticals (CPEX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 16, 2010 | CPEX | ↓ Sell | 56,000 | $15.78 | $884K | Direct | Feb 16, 2010 (0d) |
| Jan 12, 2010 | CPEX | ↑ Buy | 1,903 | $14.00 | $27K | By Arcadia Opportunity Master Fund, Ltd. | Jan 15, 2010 (3d) |
| Dec 31, 2009 | CPEX | ↑ Buy | 5,107 | $11.25 | $57K | By Arcadia Opportunity Master Fund, Ltd. | Jan 8, 2010 (8d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James S Frank's insider trades
James S Frank is a 10% owner of CPEX Pharmaceuticals (CPEX). Since Dec 31, 2009, James has reported 2 open-market purchases worth $84K and 1 sale worth $884K on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CPEX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.